Indivior Pharmaceuticals, Inc. INDV Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Indivior Pharmaceuticals, Inc. ’s reported figures.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's enterprise value?
- Indivior Pharmaceuticals, Inc. (INDV) reported enterprise value of $4.05B in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's enterprise value changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's enterprise value increased by 241.5% year-over-year, from $1.19B to $4.05B.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's enterprise value?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's enterprise value has grown at a 51.7% compound annual growth rate (CAGR), from $2.02B to $4.64B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.